Best practice in assessing ototoxicity in children with cancer.
about
Different infusion durations for preventing platinum-induced hearing loss in children with cancerMedical interventions for the prevention of platinum-induced hearing loss in children with cancerMedical interventions for the prevention of platinum-induced hearing loss in children with cancerPlatinum-induced hearing loss after treatment for childhood cancerDifferent infusion durations for preventing platinum-induced hearing loss in children with cancerMedical interventions for the prevention of platinum-induced hearing loss in children with cancerDifferent infusion durations for preventing platinum-induced hearing loss in children with cancerPlatinum-induced hearing loss after treatment for childhood cancerCo-administration of cisplatin and furosemide causes rapid and massive loss of cochlear hair cells in mice.Membrane transporters as mediators of Cisplatin effects and side effects.Organic cation transporter 2 mediates cisplatin-induced oto- and nephrotoxicity and is a target for protective interventions.Quantitative bioimaging of platinum in polymer embedded mouse organs using laser ablation ICP-MS.Cisplatin ototoxicity in rat cochlear organotypic cultures.Prospective evaluation of cisplatin- and carboplatin-mediated ototoxicity in paediatric and adult soft tissue and osteosarcoma patients.Role of transporters in the distribution of platinum-based drugs.The role of germline variants in chemotherapy outcome in brain tumors: a systematic review of pharmacogenetic studies.Impact of Undernutrition on the Pharmacokinetics and Pharmacodynamics of Anticancer Drugs: A Literature Review.The Role of Transporters in the Toxicity of Chemotherapeutic Drugs: Focus on Transporters for Organic Cations.Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.Evaluation of the effect of acetyl L-carnitine on experimental cisplatin ototoxicity and neurotoxicity.Speech recognition and frequency of hearing loss in patients treated for cancer in childhood.Early cisplatin induced ototoxicity profile may predict the need for hearing support in children with medulloblastoma.The use of high-frequency audiometry increases the diagnosis of asymptomatic hearing loss in pediatric patients treated with cisplatin-based chemotherapy.
P2860
Q24193767-53F40399-AAB8-4A8E-AFEE-95DA9614B727Q24194929-097BCD44-3947-48AD-815B-197D7B3A8694Q24197812-04567B3C-7D99-4110-8019-382F1E104723Q24197838-4EBF3A50-F943-4EE2-98AB-4947F44ADD07Q24202129-979081D6-A2E9-41A8-A447-84316F96491BQ24236069-3D4CC1AC-3522-4297-B6A6-F53FF20741B8Q26470492-2B8433ED-CDD5-4BED-BF78-A577D10BA030Q26470526-999B60E8-30D9-4333-AF7A-79C5962B61A0Q28391411-B4678F0C-A2F1-4609-9A8B-91FC06C3443EQ30446860-3DE80681-BD84-40F5-8645-05DA6F157EA9Q30476563-43114CE8-48F8-47C8-AA65-8BBDCA401D9AQ34915590-074E5887-45AE-4B41-8CD1-4FFB0B0C4E9FQ35592843-BC8ECBDD-4800-4447-A2F9-8A757E1E7720Q36475858-AE6F23E8-1E6C-4B6D-9167-67302F2B6F60Q38474594-CB9CA039-C396-45EC-B522-64B7531F651CQ38739253-7238561C-0355-48E3-99ED-E1708B4DE88AQ38869469-6C9C18CB-4806-4D6D-97D5-A5A671ABBCD3Q38888345-606F7935-F64F-4F4D-BDC7-5D1E51CE27F6Q38964704-C7A59DD0-1CE9-480A-9DB9-5CA3279B91AFQ42741636-E3413A08-176E-4CDC-B933-9A27527657E8Q44588405-B6DEDDF5-341B-40BB-842B-E90584F2CA5EQ50428964-ECB34768-AAAF-41CF-B27F-31B14DED403FQ50430194-166DDBC5-67B9-422E-A5B3-B668704C3E0D
P2860
Best practice in assessing ototoxicity in children with cancer.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Best practice in assessing ototoxicity in children with cancer.
@en
Best practice in assessing ototoxicity in children with cancer.
@nl
type
label
Best practice in assessing ototoxicity in children with cancer.
@en
Best practice in assessing ototoxicity in children with cancer.
@nl
prefLabel
Best practice in assessing ototoxicity in children with cancer.
@en
Best practice in assessing ototoxicity in children with cancer.
@nl
P1476
Best practice in assessing ototoxicity in children with cancer.
@en
P2093
Roderick Skinner
P304
P356
10.1016/J.EJCA.2004.08.002
P577
2004-11-01T00:00:00Z